Familial hypoparathyroidism: genes and variants
Explore variant evidence for Familial hypoparathyroidism across 3 analyzed proteins (CASR, GNA11, PTH). Linked ClinVar records include 2 pathogenic or likely pathogenic variants, 3 variants of uncertain significance and 0 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-04. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Familial hypoparathyroidism
CASR: Extracellular calcium-sensing receptor
It senses extracellular calcium in the parathyroid gland and kidney and adjusts parathyroid-hormone secretion and renal calcium handling accordingly. Loss-of-function variants cause familial hypocalciuric hypercalcemia or neonatal severe hyperparathyroidism, whereas activating variants cause autosomal dominant hypocalcemia.
1 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in CASR have source records linked to Familial hypoparathyroidism. Association strength is not clinical gene validity.
GNA11: Guanine nucleotide-binding protein subunit alpha-11
It transmits signals from Gq-coupled receptors to phospholipase C and downstream calcium and protein-kinase-C pathways. Germline activating variants can cause autosomal dominant hypocalcemia, while somatic activating variants drive uveal melanoma and some vascular lesions.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in GNA11 have source records linked to Familial hypoparathyroidism. Association strength is not clinical gene validity.
PTH: Parathyroid hormone
After secretion from the parathyroid glands, it raises extracellular calcium by acting on bone and kidney and indirectly increasing intestinal calcium absorption. Deficiency causes hypoparathyroidism, whereas excessive secretion produces hyperparathyroidism and characteristic skeletal and renal complications.
0 ClinVar pathogenic / likely pathogenic and 2 uncertain variants in PTH have source records linked to Familial hypoparathyroidism. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Familial hypoparathyroidism
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| CASR A645D | 645 | Intracellular loop 1 (ICL1) | Pathogenic / likely pathogenic (★) |
| GNA11 V179M | 179 | G-alpha | Pathogenic / likely pathogenic (★) |
Same protein, different disease
- Familial hypocalciuric hypercalcemia also has ClinVar records linked to CASR variants; they fall mostly in different places as the Familial hypoparathyroidism variants (81 pathogenic / likely pathogenic).
- Autosomal dominant hypocalcemia also has ClinVar records linked to CASR variants; they fall mostly in different places as the Familial hypoparathyroidism variants (69 pathogenic / likely pathogenic).
- Nephrolithiasis/nephrocalcinosis also has ClinVar records linked to CASR variants; they fall mostly in different places as the Familial hypoparathyroidism variants (14 pathogenic / likely pathogenic).
- Neonatal severe primary hyperparathyroidism also has ClinVar records linked to CASR variants; they fall mostly in different places as the Familial hypoparathyroidism variants (11 pathogenic / likely pathogenic).
- Idiopathic generalized epilepsy also has ClinVar records linked to CASR variants; they fall mostly in different places as the Familial hypoparathyroidism variants (8 pathogenic / likely pathogenic).
- Autosomal dominant hypocalcemia also has ClinVar records linked to GNA11 variants; they fall mostly in different places as the Familial hypoparathyroidism variants (6 pathogenic / likely pathogenic).
- Familial hypocalciuric hypercalcemia also has ClinVar records linked to GNA11 variants; they fall mostly in different places as the Familial hypoparathyroidism variants (4 pathogenic / likely pathogenic).
Diseases related to Familial hypoparathyroidism
- Familial hypocalciuric hypercalcemia, also linked to CASR and GNA11
- Autosomal dominant hypocalcemia, also linked to CASR and GNA11
- Hypertrophic cardiomyopathy, also linked to CASR
- Idiopathic generalized epilepsy, also linked to CASR
- Nephrolithiasis/nephrocalcinosis, also linked to CASR
- Neonatal severe primary hyperparathyroidism, also linked to CASR
- Vascular malformation, also linked to GNA11
- Familial hyperparathyroidism or Hypocalciuric hypercalcaemia, also linked to CASR
- Parathyroid carcinoma, also linked to CASR
- Familial multiple nevi flammei, also linked to GNA11
- Hypoparathyroidism, familial isolated 1, also linked to PTH
Frequently asked questions
Which genes have records linked to Familial hypoparathyroidism?
This view contains 3 analyzed proteins: CASR, GNA11, PTH. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 2 pathogenic or likely pathogenic variants, 3 variants of uncertain significance and 0 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 50 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center